Shirtaev Bakhytzhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shirtaev Bakhytzhan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Nazira Yerimova4 shared publications
- D.O. Bogdanova3 shared publications
- M.M. Sundetov3 shared publications
- S.E. Mukashev3 shared publications
- Daniel Kurbanov2 shared publications
- Gulziya Ismailova
Department of JSC, Syzganov National Scientific Center of Surgery, Almaty, Kazakhstan
2 shared publications
Latest Publications
- 31 December 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (4) , 25-33
COMBINED SURGERY OF LUNG ECHINOCOCCOSIS
Background. Pulmonary cystic echinococosis, a parasitic disease, is a health care problem in developing countries. In this study, we evaluated outcomes of patients with pulmonary hydatid disease who were treated in our department.Study was performed to compare results of surgical treatment and complications of patients with unilateral or bilateral thoracic and combined pulmonary cystic echinococosis. Methods. This cross-sectional analysis of a prospective study was conducted in the Department of Thoracic and Pediatric Surgery, Scientific Center of Surgery, Almaty, Kazakhstan among 598 patients with pulmonary cystic echinococosis, who had surgical treatment with various surgical methods, depending on the prevalence of echinococcosis, as follows: right lung in 357 (59.5%) patients, left lung in 243 (40.5%) patients, bilateral in 95 (15.8%) patients, and complicated echinococcosis in 317 (52.8%) patients. Length of stay per hospital stay has been decreased (p 0.0001) by video-thoracoscopicechinococcectomy with the high-energy laser treatment of cyst, than after echinococcectomy by cyst treatment with povidone-iodine. Treatment with formalin presented the longest hospital stay (p 0.0001). Results. Comparative analysis of patients with uncomplicated and complicated pulmonary cystic echinococosis showed a high frequency of postoperative complications associated with complicated echinococcosis (OR = 2.2, p 0.0001). Conclusion. Despite the success of surgical treatment of pulmonary cystic echinococosis, issues of intraoperative dissemination and safety remain, and treatment success rates can be improved. These factors require further prospective multicenter studies.
- 31 December 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (4) , 25-33
COMBINED SURGERY OF LUNG ECHINOCOCCOSIS
Background. Pulmonary cystic echinococosis, a parasitic disease, is a health care problem in developing countries. In this study, we evaluated outcomes of patients with pulmonary hydatid disease who were treated in our department.Study was performed to compare results of surgical treatment and complications of patients with unilateral or bilateral thoracic and combined pulmonary cystic echinococosis. Methods. This cross-sectional analysis of a prospective study was conducted in the Department of Thoracic and Pediatric Surgery, Scientific Center of Surgery, Almaty, Kazakhstan among 598 patients with pulmonary cystic echinococosis, who had surgical treatment with various surgical methods, depending on the prevalence of echinococcosis, as follows: right lung in 357 (59.5%) patients, left lung in 243 (40.5%) patients, bilateral in 95 (15.8%) patients, and complicated echinococcosis in 317 (52.8%) patients. Length of stay per hospital stay has been decreased (p 0.0001) by video-thoracoscopicechinococcectomy with the high-energy laser treatment of cyst, than after echinococcectomy by cyst treatment with povidone-iodine. Treatment with formalin presented the longest hospital stay (p 0.0001). Results. Comparative analysis of patients with uncomplicated and complicated pulmonary cystic echinococosis showed a high frequency of postoperative complications associated with complicated echinococcosis (OR = 2.2, p 0.0001). Conclusion. Despite the success of surgical treatment of pulmonary cystic echinococosis, issues of intraoperative dissemination and safety remain, and treatment success rates can be improved. These factors require further prospective multicenter studies.
- 1 October 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 3,p. 25-28
SURGERY OF CONGENITAL BRONCHEECTASES IN CHILDREN AND ADULTS
The overwhelming majority of thoracic and pediatric surgeons are of the opinion that it is necessary to perform early surgeries for congenital bronchiectasis, since bronchial dilatation leads to infection of bronchial contents and repeated exacerbations of the inflammatory process, but some pediatricians express a reserved attitude to operations in childhood, adhering to long-term follow-up tactics. Purpose. To present statistical data on the situation of patients with congenital bronchiectasis of different age categories and to offer separate recommendations for the treatment and diagnosis of patients with congenital bronchiectasis. Material and methods. 433 patients with congenital bronchiectasis were operated in our clinic, which was 50.9% of all congenital lung malformations. The patients’ age ranged from 2 to 65 years. There were more children and adolescents (60.9%) than adults (39.1%). Results. The article presents the results of diagnostics and surgical treatment of 433 patients with congenital bronchiectasis. It was found that the immediate and long-term results of surgical treatment of children are better than those of adult patients
- 1 October 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 3,p. 25-28
SURGERY OF CONGENITAL BRONCHEECTASES IN CHILDREN AND ADULTS
The overwhelming majority of thoracic and pediatric surgeons are of the opinion that it is necessary to perform early surgeries for congenital bronchiectasis, since bronchial dilatation leads to infection of bronchial contents and repeated exacerbations of the inflammatory process, but some pediatricians express a reserved attitude to operations in childhood, adhering to long-term follow-up tactics. Purpose. To present statistical data on the situation of patients with congenital bronchiectasis of different age categories and to offer separate recommendations for the treatment and diagnosis of patients with congenital bronchiectasis. Material and methods. 433 patients with congenital bronchiectasis were operated in our clinic, which was 50.9% of all congenital lung malformations. The patients’ age ranged from 2 to 65 years. There were more children and adolescents (60.9%) than adults (39.1%). Results. The article presents the results of diagnostics and surgical treatment of 433 patients with congenital bronchiectasis. It was found that the immediate and long-term results of surgical treatment of children are better than those of adult patients
- 1 July 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 2,p. 37-41
PROBLEMS OF ANTIBIOTIC RESISTANCE IN CHILDREN AFTER LIVER TRANSPLANTATION
- 1 July 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 2,p. 37-41
PROBLEMS OF ANTIBIOTIC RESISTANCE IN CHILDREN AFTER LIVER TRANSPLANTATION
- 1 March 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 1,p. 55-59
THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD
The article reflects the role of non-steroidal anti-inflammatory drugs in postoperative period. The study was conducted on the data of 94 operations of children aged from 10 months to 15 years (mean age 4.4 years). All patients of our center with esophagocoloplasty in the postoperative period received the drug «Intrafen» in injectable form, intravenously. Name of manufacturer of drug: GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET, A.S. (Turkey). The main active substance of this drug is Ibuprofen 400mg/4ml for intravenous injection. Patients were injected intravenous ibuprofen at therapeutically effective doses for a minimal period of time. After receiving positive reactions to the drug at the initial stage of treatment, the dose and frequency of taking the drug was adjusted individually for each patient. Objective. This work is dedicated to evaluate the role of the intravenous Ibuprofen in the postoperative period in surgical practice. Material and methods. The study included 94 pediatric patients with esophagocoloplasty. Age of patients: from 10 months to 15 years (mean age 4.4 years), of which: 90 (96%) patients had post-burn stricture of the esophagus; 3 (3%) patients with esophageal atresia; 1 (1%) patient with a short esophagus. The number of female children - 51 (54.3%) patients, male - 43 (45.7%) patients. Results. The total number of patients receiving intravenous Ibuprofen in the postoperative period was 94. The optimal dose showed a good therapeutic effect. At the optimal dosage of 20 mg/kg/day, two patients experienced intra-abdominal bleeding. Follow-up time: 2 weeks after esophagocoloplasty. Conclusion. In patients with esophagocoloplasty, preventive intravenous administration of Ibuprofen showed a good therapeutic result. Patients noted a decrease in pain, which in turn led to a decrease in the need for emergency analgesia.
- 1 March 2022
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- No. 1,p. 55-59
THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD
The article reflects the role of non-steroidal anti-inflammatory drugs in postoperative period. The study was conducted on the data of 94 operations of children aged from 10 months to 15 years (mean age 4.4 years). All patients of our center with esophagocoloplasty in the postoperative period received the drug «Intrafen» in injectable form, intravenously. Name of manufacturer of drug: GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET, A.S. (Turkey). The main active substance of this drug is Ibuprofen 400mg/4ml for intravenous injection. Patients were injected intravenous ibuprofen at therapeutically effective doses for a minimal period of time. After receiving positive reactions to the drug at the initial stage of treatment, the dose and frequency of taking the drug was adjusted individually for each patient. Objective. This work is dedicated to evaluate the role of the intravenous Ibuprofen in the postoperative period in surgical practice. Material and methods. The study included 94 pediatric patients with esophagocoloplasty. Age of patients: from 10 months to 15 years (mean age 4.4 years), of which: 90 (96%) patients had post-burn stricture of the esophagus; 3 (3%) patients with esophageal atresia; 1 (1%) patient with a short esophagus. The number of female children - 51 (54.3%) patients, male - 43 (45.7%) patients. Results. The total number of patients receiving intravenous Ibuprofen in the postoperative period was 94. The optimal dose showed a good therapeutic effect. At the optimal dosage of 20 mg/kg/day, two patients experienced intra-abdominal bleeding. Follow-up time: 2 weeks after esophagocoloplasty. Conclusion. In patients with esophagocoloplasty, preventive intravenous administration of Ibuprofen showed a good therapeutic result. Patients noted a decrease in pain, which in turn led to a decrease in the need for emergency analgesia.
- Open Access
- 1 January 2018
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 39 (1) , 31-37
Single-center experience in the surgical treatment of combined lung Echinococcosis
Single-center experience in the surgical treatment of combined lung Echinococcosis
- 1 January 2018
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 39 (1) , 31-37
Open AccessSingle-center experience in the surgical treatment of combined lung Echinococcosis
Single-center experience in the surgical treatment of combined lung Echinococcosis